Collectively, these findings establish HSP90AA1 as a central regulator of COPD pathogenesis, influencing goblet cell metaplasia, steroid resistance, and chronic inflammation, thereby representing a promising therapeutic target for modulating disease progression and restoring treatment efficacy. The gene discussed is HSP90AA1; the disease is chronic obstructive pulmonary disease.